Community Practice Connections: 1st Annual European Congress on Genitourinary Malignancies
WebcastFaculty
OVERVIEW
Community Practice Connections: 1st Annual European Congress on Genitourinary Malignancies is organized by Physicians Education Resource, LLC (PER) and will be held during Sep 29, 2017 - Sep 29, 2018.
The target audience for this medical event is intended for medical, surgical, and radiation oncologists, as well as other healthcare professionals involved in the treatment and management of patients with GU malignancies. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Overview :
This Conference features a summary of clinical evidence guiding best practices in the treatment of patients with genitourinary (GU) cancers, including recent developments with targeted agents and immunotherapy. Interactive clinical vignettes are followed by short video interviews with internationally renowned experts in the management of patients with GU malignancies. The video interviews address decision points in the clinical vignettes and questions commonly faced in the community oncology practice setting by medical professionals engaged in the care of patients with renal cell carcinoma, urothelial carcinoma, and prostate cancer.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe methods to stratify risk and apply tumor information to inform clinical decision making in the management of GU malignancies
• Summarize clinical trial evidence and recommendations that shape evolving strategies to care for patients with GU malignancies
• Evaluate recent practice-changing clinical trial data concerning novel compounds or strategies to manage GU malignancies
• Discuss how emerging clinical concepts and findings in the management of GU malignancies fit into evolving treatment paradigms in the field
Additional details will be posted as soon as they are available.
The target audience for this medical event is intended for medical, surgical, and radiation oncologists, as well as other healthcare professionals involved in the treatment and management of patients with GU malignancies. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Overview :
This Conference features a summary of clinical evidence guiding best practices in the treatment of patients with genitourinary (GU) cancers, including recent developments with targeted agents and immunotherapy. Interactive clinical vignettes are followed by short video interviews with internationally renowned experts in the management of patients with GU malignancies. The video interviews address decision points in the clinical vignettes and questions commonly faced in the community oncology practice setting by medical professionals engaged in the care of patients with renal cell carcinoma, urothelial carcinoma, and prostate cancer.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe methods to stratify risk and apply tumor information to inform clinical decision making in the management of GU malignancies
• Summarize clinical trial evidence and recommendations that shape evolving strategies to care for patients with GU malignancies
• Evaluate recent practice-changing clinical trial data concerning novel compounds or strategies to manage GU malignancies
• Discuss how emerging clinical concepts and findings in the management of GU malignancies fit into evolving treatment paradigms in the field
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links